MarketPeel
Insider Trading Intelligence
Pricing
…
JA

James M. Ahlers

CUE
CHIEF FINANCIAL OFFICER · CUE BIOPHARMA, INC. · CIK 0001320383
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2026
HOLDINGS NOW
51,000
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for James M. Ahlers. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
CUE · 51,000 shares · as of Jul 30, 2026
012,75025,50038,25051,000SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
51,000——51,000Jul 30, 2026Aug 3, 2026 ↗View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
25,500——25,500Jul 30, 2026Aug 3, 2026 ↗View →
Other insiders · CUE
Loading peer insiders…
About this filer
CIK 0001320383
ROLE
Chief Financial Officer
PRIMARY
CUE
COMPANIES
1
ACTIVE SINCE
Jul 2026
MARKETPEEL · /INSIDER/0001320383DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback